Advocacy

AACR Update

Research Advocate Seana Roubinek attended the 2015 American Association of Cancer Research Annual Meeting in April…

Read on

New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing

FOR IMMEDIATE RELEASE May 12, 2015 Contact: Lisa Mauti lmauti@ovariancancer.org (202) 517-6410 New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing WASHINGTON, DC—Yesterday, the U.S…

Read on

ACA Update

New Affordable Care Act guidance says women with ovarian cancer can receive free genetic counseling, testing. On May 11, 2015, the U.S…

Read on

Pelvic Exam Guidelines

The American College of Physicians recently recommended that women do not need to have a pelvic exam on an annual basis…

Read on

Report from the 2014 American Society of Clinical Oncology Annual Meeting

Promising new combination treatments for ovarian cancer Dr…

Read on

2014 ASCO Research Round-Up

Posted by Laura Koontz on June 5, 2014 The 50th Annual Conference of the American Society of Clinical Oncology, held May 30 – June 3 in Chicago, featured a number of promising and thought provoking studies on ovarian cancer…

Read on

Few women offered genetic counseling services for breast and ovarian cancer risk

Despite recommendations from the federal government that women at high-risk of developing breast and ovarian cancer be offered genetic counseling and testing at no out of pocket cost, a new study finds that few women are offered these services…

Read on

Alliance submits comments to FDA on off-label use of oncology drugs

This week, the Ovarian Cancer National Alliance submitted comments to the Food and Drug Administration (FDA) about a proposed Guidance for Industry that could have the effect of limiting patient access to “off label” oncology drugs…

Read on

SGO and AACR Research Round-Up

With two marquee scientific conferences, the Society for Gynecologic Oncology (SGO) and the American Association for Cancer Research (AACR), occurring back-to-back, the past few weeks have seen an explosion in ovarian cancer research news…

Read on

108 Members of the House of Representative Support Ovarian Cancer Research Funding

Each spring, Congress takes up the task of allocating money to federal programs. And each spring, the Ovarian Cancer National Alliance works to ensure that ovarian cancer research funding remains a top priority. This year was no exception…

Read on

Updates from the 2014 Society for Gynecologic Oncology Annual Meeting

Compiled by Robin Cohen, President-Elect, Ovarian Cancer National Alliance As in years past, a wealth of clinical research into ovarian cancer was presented at the 2014 Society for Gynecologic Oncology (SGO) meeting…

Read on

Vynfinit gains European approval for treatment of platinum-resistant ovarian cancer

Last week, the European Medicines Agency’s Committee for Medicinal Products for Human Use, or CHMP – the equivalent to the FDA in the United States, recommended approval for vynfinit in the treatment of some platinum resistant ovarian…

Read on